GILEAD SCIENCES INC Insider Trading for February 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GILEAD SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in GILEAD SCIENCES INC for February 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP,Corporate &Medi ... | Payment of Exercise | F | 80.69 | 5,894 | 475,587 | 52,176 | 58.1 K to 52.2 K (-10.15 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP,Corporate &Medi ... | Grant | A | 0.00 | 5,672 | 0 | 58,070 | 52.4 K to 58.1 K (+10.82 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP,Corporate &Medi ... | Grant | A | 0.00 | 14,320 | 0 | 52,398 | 38.1 K to 52.4 K (+37.61 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP,Corporate &Medi ... | Grant | A | 62.35 | 340 | 21,198 | 38,078 | 37.7 K to 38.1 K (+0.90 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Payment of Exercise | F | 80.69 | 5,690 | 459,126 | 24,089 | 29.8 K to 24.1 K (-19.11 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Grant | A | 0.00 | 5,183 | 0 | 29,779 | 24.6 K to 29.8 K (+21.07 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Grant | A | 0.00 | 14,654 | 0 | 24,596 | 9.9 K to 24.6 K (+147.39 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Grant | A | 62.35 | 340 | 21,198 | 9,942 | 9.6 K to 9.9 K (+3.54 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Payment of Exercise | F | 80.69 | 8,009 | 646,246 | 1,214,306 | 1.2 M to 1.2 M (-0.66 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Grant | A | 0.00 | 7,709 | 0 | 1,222,315 | 1.2 M to 1.2 M (+0.63 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Grant | A | 0.00 | 48,342 | 0 | 1,214,606 | 1.2 M to 1.2 M (+4.15 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Grant | A | 62.35 | 340 | 21,198 | 1,166,264 | 1.2 M to 1.2 M (+0.03 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Gift | G | 0.00 | 9,393 | 0 | 2,317,800 | 2.3 M to 2.3 M (+0.41 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Gift | G | 0.00 | 9,393 | 0 | 19,602 | 29 K to 19.6 K (-32.40 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Payment of Exercise | F | 80.69 | 7,071 | 570,559 | 28,995 | 36.1 K to 29 K (-19.61 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Grant | A | 0.00 | 6,805 | 0 | 36,066 | 29.3 K to 36.1 K (+23.26 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Grant | A | 0.00 | 16,468 | 0 | 29,261 | 12.8 K to 29.3 K (+128.73 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Grant | A | 62.35 | 340 | 21,198 | 12,793 | 12.5 K to 12.8 K (+2.73 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Payment of Exercise | F | 80.69 | 19,354 | 1,561,674 | 3,017,762 | 3 M to 3 M (-0.64 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Grant | A | 0.00 | 18,630 | 0 | 3,037,116 | 3 M to 3 M (+0.62 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Grant | A | 0.00 | 21,380 | 0 | 3,018,486 | 3 M to 3 M (+0.71 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Grant | A | 62.35 | 340 | 21,198 | 2,997,106 | 3 M to 3 M (+0.01 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | Chief Operating Off ... | Grant | A | 0.00 | 9,460 | 0 | 25,612 | 16.2 K to 25.6 K (+58.57 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | Chief Operating Off ... | Grant | A | 62.35 | 340 | 21,198 | 16,152 | 15.8 K to 16.2 K (+2.15 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Gift | G | 0.00 | 2,323 | 0 | 132,083 | 129.8 K to 132.1 K (+1.79 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Gift | G | 0.00 | 2,323 | 0 | 5,393 | 7.7 K to 5.4 K (-30.11 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Payment of Exercise | F | 80.69 | 1,647 | 132,896 | 7,716 | 9.4 K to 7.7 K (-17.59 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Grant | A | 0.00 | 1,581 | 0 | 9,363 | 7.8 K to 9.4 K (+20.32 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Grant | A | 0.00 | 4,846 | 0 | 7,782 | 2.9 K to 7.8 K (+165.05 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Grant | A | 62.35 | 221 | 13,779 | 2,936 | 2.7 K to 2.9 K (+8.14 %) |
| Feb 21 2018 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP,Corporate &Medi ... | Sell | S | 81.54 | 14,435 | 1,176,992 | 0 | 14.4 K to 0 (-100.00 %) |
| Feb 13 2018 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Option Exercise | M | 26.62 | 60,000 | 1,596,900 | 0 | |
| Feb 13 2018 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Sell | S | 77.92 | 60,000 | 4,675,080 | 122,258 | 182.3 K to 122.3 K (-32.92 %) |
| Feb 13 2018 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Buy | M | 26.62 | 60,000 | 1,596,900 | 182,258 | 122.3 K to 182.3 K (+49.08 %) |
| Feb 05 2018 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Option Exercise | A | 83.49 | 75,490 | 6,302,660 | 75,490 | |
| Feb 05 2018 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Option Exercise | A | 83.49 | 295,660 | 24,684,653 | 295,660 | |
| Feb 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 23.60 | 50,000 | 1,180,000 | 500,000 | |
| Feb 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 83.69 | 30,723 | 2,571,125 | 2,996,766 | 3 M to 3 M (-1.01 %) |
| Feb 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 83.35 | 19,277 | 1,606,699 | 3,027,489 | 3 M to 3 M (-0.63 %) |
| Feb 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 23.60 | 50,000 | 1,180,000 | 3,046,766 | 3 M to 3 M (+1.67 %) |
| Feb 05 2018 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP,Corporate &Medi ... | Option Exercise | A | 83.49 | 62,910 | 5,252,356 | 62,910 | |
| Feb 05 2018 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP,Corporate &Medi ... | Option Exercise | M | 40.56 | 17,250 | 699,660 | 72,846 | |
| Feb 05 2018 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP,Corporate &Medi ... | Sell | S | 83.66 | 15,214 | 1,272,805 | 37,738 | 53 K to 37.7 K (-28.73 %) |
| Feb 05 2018 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP,Corporate &Medi ... | Sell | S | 83.29 | 9,786 | 815,055 | 52,952 | 62.7 K to 53 K (-15.60 %) |
| Feb 05 2018 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP,Corporate &Medi ... | Buy | M | 40.56 | 17,250 | 699,660 | 62,738 | 45.5 K to 62.7 K (+37.92 %) |
| Feb 05 2018 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | A | 83.49 | 94,360 | 7,878,116 | 94,360 | |
| Feb 05 2018 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Option Exercise | A | 83.49 | 100,650 | 8,403,269 | 100,650 | |
| Feb 02 2018 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | Chief Operating Off ... | Option Exercise | M | 0.00 | 620 | 0 | 4,092 | |
| Feb 02 2018 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | Chief Operating Off ... | Payment of Exercise | F | 83.49 | 218 | 18,201 | 15,329 | 15.5 K to 15.3 K (-1.40 %) |
| Feb 02 2018 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | Chief Operating Off ... | Buy | M | 0.00 | 620 | 0 | 15,547 | 14.9 K to 15.5 K (+4.15 %) |
| Feb 02 2018 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | Chief Operating Off ... | Payment of Exercise | F | 83.80 | 2,259 | 189,304 | 14,927 | 17.2 K to 14.9 K (-13.14 %) |
| Feb 02 2018 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | Chief Operating Off ... | Grant | A | 0.00 | 7,110 | 0 | 17,186 | 10.1 K to 17.2 K (+70.56 %) |
| Feb 02 2018 | GILD | GILEAD SCIENCES IN ... | BARTON JACQUELINE K | Director | Option Exercise | A | 0.00 | 480 | 0 | 480 | |
| Feb 02 2018 | GILD | GILEAD SCIENCES IN ... | BARTON JACQUELINE K | Director | Option Exercise | A | 83.80 | 2,119 | 177,572 | 2,119 |